The semaglutide impurity des-10-Val-SMT is a structural defect impurity that may be produced during the synthesis or degradation of semaglutide. Semaglutide is a long-acting GLP-1 analogue, mainly used to treat type 2 diabetes and obesity. This impurity is different from the standard drug molecule structure due to the lack of the valine (Val) residue at the 10th position, which may affect the purity and biological activity of the drug. Therefore, its content needs to be strictly monitored in drug quality control.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Asp-Val-Arg-Arg-Arg-Arg-Arg-Arg-Gly-CONH2 |
Single letter sequence |
HHAEGTFTSDVSSYLEGQAKKEFIAWLVKGDVRRAARRRRG-NH2 |
Molecular formula |
C183H284N51O56S |
Molecular weight |
4034.16 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |